Reinholdt J, Tomana M, Mortensen S B, Kilian M
Department of Oral Biology, Royal Dental College, Aarhus C, Denmark.
Infect Immun. 1990 May;58(5):1186-94. doi: 10.1128/iai.58.5.1186-1194.1990.
Using a panel of 143 strains classified according to a novel taxonomic system for oral viridans-type streptococci, we reexamined the ability of oral streptococci to attack human immunoglobulin A1 (IgA1) molecules with IgA1 protease or glycosidases. IgA1 protease production was an exclusive property of all strains belonging to Streptococcus sanguis and Streptococcus oralis (previously S. mitior) and of some strains of Streptococcus mitis biovar 1. These are all dominant initiators of dental plaque formation. Degradation of the carbohydrate moiety of IgA1 molecules accompanied IgA1 protease activity in S. oralis and protease-producing strains of S. mitis biovar 1. Neuraminidase and beta-galactosidase were identified as extracellular enzymes in organisms of these taxa. By examination with enzyme-neutralizing antisera, four distinct IgA1 proteases were detected in S. sanguis biovars 1 to 3, S. sanguis biovar 4, S. oralis, and strains of S. mitis, respectively. The cleavage of IgA1 molecules by streptococcal IgA proteases was found to be influenced by their state of glycosylation. Treatment of IgA1 with bacterial (including streptococcal) neuraminidase increased susceptibility to protease, suggesting a cooperative activity of streptococcal IgA1 protease and neuraminidase. In contrast, a decrease in susceptibility was observed after extensive deglycosylation of the hinge region with endo-alpha-N acetylgalactosaminidase. The effector functions of IgA antibodies depend on the carbohydrate-containing Fc portion. Hence, the observation that oral streptococci may cleave not only the alpha 1 chains but also the carbohydrate moiety of IgA1 molecules suggests that the ability to evade secretory immune mechanisms may contribute to the successful establishment of these bacteria in the oral cavity.
利用一组根据口腔草绿色链球菌新分类系统分类的143株菌株,我们重新研究了口腔链球菌用IgA1蛋白酶或糖苷酶攻击人免疫球蛋白A1(IgA1)分子的能力。IgA1蛋白酶的产生是血链球菌、口腔链球菌(以前称为轻型链球菌)的所有菌株以及缓症链球菌生物变种1的一些菌株的独有特性。这些都是牙菌斑形成的主要起始菌。在口腔链球菌和缓症链球菌生物变种1的产蛋白酶菌株中,IgA1分子碳水化合物部分的降解伴随着IgA1蛋白酶活性。神经氨酸酶和β-半乳糖苷酶被鉴定为这些分类群生物中的胞外酶。通过用酶中和抗血清检测,分别在血链球菌生物变种1至3、血链球菌生物变种4、口腔链球菌和缓症链球菌菌株中检测到四种不同的IgA1蛋白酶。发现链球菌IgA蛋白酶对IgA1分子的切割受其糖基化状态的影响。用细菌(包括链球菌)神经氨酸酶处理IgA1会增加其对蛋白酶的敏感性,这表明链球菌IgA1蛋白酶和神经氨酸酶具有协同活性。相反,用内切α-N-乙酰半乳糖胺酶对铰链区进行广泛去糖基化后,观察到敏感性降低。IgA抗体的效应功能取决于含碳水化合物的Fc部分。因此,口腔链球菌不仅可能切割IgA1分子的α1链,还可能切割其碳水化合物部分,这一观察结果表明,逃避分泌免疫机制的能力可能有助于这些细菌在口腔中成功定植。